Stay updated on FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial

Sign up to get notified when there's something new on the FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    - Added a government operating status notice and a version bump to v3.2.0. - Removed the old version tag v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T08:25:22.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T05:12:25.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2. The Back to Top element has been removed.
    Difference
    0.1%
    Check dated 2025-09-14T23:13:08.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.1%
    Check dated 2025-09-07T19:50:33.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and various locations across multiple countries, while removing outdated location references and certain genetic disease information.
    Difference
    17%
    Check dated 2025-08-31T12:33:12.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-08-17T04:46:22.000Z thumbnail image

Stay in the know with updates to FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial page.